ATE290393T1 - Milchsäurebakterien zur behandlung und prophylaxe von giardiasis - Google Patents
Milchsäurebakterien zur behandlung und prophylaxe von giardiasisInfo
- Publication number
- ATE290393T1 ATE290393T1 AT00971377T AT00971377T ATE290393T1 AT E290393 T1 ATE290393 T1 AT E290393T1 AT 00971377 T AT00971377 T AT 00971377T AT 00971377 T AT00971377 T AT 00971377T AT E290393 T1 ATE290393 T1 AT E290393T1
- Authority
- AT
- Austria
- Prior art keywords
- giardiasis
- prophylaxis
- treatment
- lactic acid
- acid bacteria
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1236—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using Leuconostoc, Pediococcus or Streptococcus sp. other than Streptococcus Thermophilus; Artificial sour buttermilk in general
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Nutrition Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Dairy Products (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99121356 | 1999-10-26 | ||
PCT/EP2000/010105 WO2001030365A1 (en) | 1999-10-26 | 2000-10-13 | Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE290393T1 true ATE290393T1 (de) | 2005-03-15 |
Family
ID=8239282
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00971377T ATE290393T1 (de) | 1999-10-26 | 2000-10-13 | Milchsäurebakterien zur behandlung und prophylaxe von giardiasis |
Country Status (19)
Country | Link |
---|---|
US (2) | US6905679B1 (de) |
EP (1) | EP1227827B1 (de) |
CN (1) | CN1281220C (de) |
AP (1) | AP1563A (de) |
AR (1) | AR026248A1 (de) |
AT (1) | ATE290393T1 (de) |
AU (1) | AU1025001A (de) |
BR (1) | BR0015102B1 (de) |
CA (1) | CA2388952C (de) |
CO (1) | CO5280049A1 (de) |
DE (1) | DE60018591T2 (de) |
DK (1) | DK1227827T3 (de) |
ES (1) | ES2239622T3 (de) |
MX (1) | MXPA02004115A (de) |
OA (1) | OA12074A (de) |
PE (1) | PE20010676A1 (de) |
PT (1) | PT1227827E (de) |
WO (1) | WO2001030365A1 (de) |
ZA (1) | ZA200203008B (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001030365A1 (en) | 1999-10-26 | 2001-05-03 | Societe Des Produits Nestle S.A. | Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis |
GB0124580D0 (en) | 2001-10-12 | 2001-12-05 | Univ Reading | New composition |
US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
AR052472A1 (es) | 2005-05-31 | 2007-03-21 | Iams Company | Lactobacilos probioticos para felinos |
EP1885383B1 (de) | 2005-05-31 | 2016-09-21 | IAMS Europe B.V. | Katzen probiotisches bifidobacterium |
WO2008093303A2 (en) | 2007-02-01 | 2008-08-07 | The Iams Company | Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts |
US9771199B2 (en) * | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
US9232813B2 (en) * | 2008-07-07 | 2016-01-12 | The Iams Company | Probiotic supplement, process for making, and packaging |
PT2429539T (pt) * | 2009-05-11 | 2017-01-12 | Nestec Sa | Lactobacilos johnsonii la1 ncc533 não replicativo (cncm i-1225) e distúrbios imunitários |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
EP3011966A1 (de) | 2014-08-08 | 2016-04-27 | Institut National De La Recherche Agronomique | Zusammensetzungen zur Hemmung von Giardia Lamblia |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69219768T2 (de) | 1992-07-06 | 1997-08-28 | Societe Des Produits Nestle S.A., Vevey | Milchbakterien |
SE9501056D0 (sv) * | 1995-03-23 | 1995-03-23 | Probi Ab | Epithelial adherent lactobacilli |
US5902578A (en) | 1996-03-25 | 1999-05-11 | Abbott Laboratories | Method and formula for the prevention of diarrhea |
DE69919130T3 (de) * | 1999-04-30 | 2008-11-27 | Société des Produits Nestlé S.A. | Erhöhtes Wachstum von Milchsäurebakterien im Milch |
WO2001030365A1 (en) | 1999-10-26 | 2001-05-03 | Societe Des Produits Nestle S.A. | Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis |
-
2000
- 2000-10-13 WO PCT/EP2000/010105 patent/WO2001030365A1/en active Search and Examination
- 2000-10-13 DK DK00971377T patent/DK1227827T3/da active
- 2000-10-13 OA OA1200200121A patent/OA12074A/en unknown
- 2000-10-13 AT AT00971377T patent/ATE290393T1/de not_active IP Right Cessation
- 2000-10-13 CN CNB008147795A patent/CN1281220C/zh not_active Expired - Fee Related
- 2000-10-13 AU AU10250/01A patent/AU1025001A/en not_active Abandoned
- 2000-10-13 US US10/111,258 patent/US6905679B1/en not_active Expired - Lifetime
- 2000-10-13 ES ES00971377T patent/ES2239622T3/es not_active Expired - Lifetime
- 2000-10-13 DE DE60018591T patent/DE60018591T2/de not_active Expired - Lifetime
- 2000-10-13 BR BRPI0015102-5A patent/BR0015102B1/pt not_active IP Right Cessation
- 2000-10-13 PT PT00971377T patent/PT1227827E/pt unknown
- 2000-10-13 CA CA002388952A patent/CA2388952C/en not_active Expired - Fee Related
- 2000-10-13 EP EP00971377A patent/EP1227827B1/de not_active Expired - Lifetime
- 2000-10-13 AP APAP/P/2002/002483A patent/AP1563A/en active
- 2000-10-13 MX MXPA02004115A patent/MXPA02004115A/es active IP Right Grant
- 2000-10-17 PE PE2000001105A patent/PE20010676A1/es not_active Application Discontinuation
- 2000-10-25 CO CO00081241A patent/CO5280049A1/es not_active Application Discontinuation
- 2000-10-26 AR ARP000105634A patent/AR026248A1/es unknown
-
2002
- 2002-04-16 ZA ZA200203008A patent/ZA200203008B/xx unknown
-
2005
- 2005-04-20 US US11/111,255 patent/US7229616B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE60018591T2 (de) | 2006-04-13 |
WO2001030365A1 (en) | 2001-05-03 |
ES2239622T3 (es) | 2005-10-01 |
BR0015102B1 (pt) | 2014-03-18 |
PT1227827E (pt) | 2005-07-29 |
DE60018591D1 (de) | 2005-04-14 |
AP2002002483A0 (en) | 2002-06-30 |
EP1227827A1 (de) | 2002-08-07 |
CA2388952C (en) | 2008-06-10 |
US6905679B1 (en) | 2005-06-14 |
OA12074A (en) | 2006-05-04 |
EP1227827B1 (de) | 2005-03-09 |
US20050186191A1 (en) | 2005-08-25 |
DK1227827T3 (da) | 2005-07-11 |
BR0015102A (pt) | 2002-07-16 |
CO5280049A1 (es) | 2003-05-30 |
CN1382056A (zh) | 2002-11-27 |
CN1281220C (zh) | 2006-10-25 |
AP1563A (en) | 2006-02-02 |
AU1025001A (en) | 2001-05-08 |
US7229616B2 (en) | 2007-06-12 |
AR026248A1 (es) | 2003-02-05 |
MXPA02004115A (es) | 2002-10-17 |
CA2388952A1 (en) | 2001-05-03 |
ZA200203008B (en) | 2003-09-23 |
PE20010676A1 (es) | 2001-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE325614T1 (de) | Milchsäurebakterienkombination und deren verwendung zur behandlung und prävention von infektionen und entzündungen | |
DE60023128D1 (de) | Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen | |
DE50009504D1 (de) | Verwendung von retigabin zur behandlung von neuropathischen schmerzen | |
DE60019556D1 (de) | 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit | |
DE69940131D1 (de) | Mittel zur Behandlung von Erkrankungen der Speiseröhre | |
ATE305306T1 (de) | Reboxetin zur behandlung von peripheren neuropathien | |
ATE251903T1 (de) | Verwendung von phosphororganischen verbindungen zur therapeutischen und prophylaktischen behandlung von infektionen | |
DE60223694D1 (de) | Pflaster zur behandlung von funktionsstörungen und störungen des nagelwachstums | |
DE60108080D1 (de) | Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen | |
DE60019555D1 (de) | 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit | |
IL157468A0 (en) | Lactic acid bacteria as agents for treating and preventing allergy | |
DE10082139T1 (de) | Zusammensetzung zur Behandlung von Reibungspaaren | |
ATE290393T1 (de) | Milchsäurebakterien zur behandlung und prophylaxe von giardiasis | |
DE60139783D1 (de) | Gen und pflanzenextrakte, wirksam zur behandlung und prävention von chlamydieninfektionen | |
DE69943089D1 (de) | Methode zur behandlung von staphylokokkeninfektionen | |
DE60027429D1 (de) | Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien | |
ATE418552T1 (de) | Substituierte amino-furan-2-yl-essigsaure- und amino-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz | |
ATE234617T1 (de) | Verwendung des saredutant und seiner pharmazeutisch akzeptablen salze zur behandlung von schwere depression | |
ATE299371T1 (de) | Antikonvulsiva zur behandlung von autismus | |
DE60018200D1 (de) | Verwendung von pleuromutilinderivaten zur transdermalen behandlung bakterieller erkrankungen | |
NO20024488D0 (no) | Anvendelse av melkesyrebakterier for behandling av bukhinnebetennelse | |
DE60036723D1 (de) | Mesoprogestine zur behandlung und vorbeugung von hormonabhängigen gutartigen gynekologischen störungen | |
DE60233740D1 (de) | Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit | |
DE69934336D1 (de) | Verwendung von halofuginone zur behandlung von urethralstriktur | |
ATE226440T1 (de) | Zusammensetzung zur behandlung von psoriasis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1227827 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |